Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
osteoporosis drug
Pharma
2 investment firms buy Radius, bone drug Tymlos for $890M
Radius Health has been bought out by two investment firms for $890 million. The company's osteoporosis drug Tymlos accounted for $219M last year.
Kevin Dunleavy
Jun 23, 2022 11:30am
Entera moves oral rival to Lilly's Forteo toward pivotal trial
Oct 11, 2021 7:30am
Amgen prices bone drug Evenity on par with rival Tymlos
Apr 16, 2019 12:18pm
Amgen bone drug Evenity wins FDA nod, but with strings attached
Apr 10, 2019 10:38am
Can Amgen's Evenity rebound? FDA, analysts aren't so sure
Jan 14, 2019 12:20pm
Amgen leaves celeb Blythe Danner behind in newest Prolia ad
Sep 19, 2018 8:51am
